#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Complex regional pain syndrome Hereditary hypophosphataemic rickets Chondrosarcoma Amyloidosis Arterial disorder Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Anal fistula Canavan disease Adrenocortical carcinoma B-cell small lymphocytic lymphoma recurrent Polycystic liver disease Congenital ectodermal dysplasia Squamous cell carcinoma of the hypopharynx Giant cell tumour of tendon sheath Head and neck cancer More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Myelodysplastic syndrome – Basic Information Netherton’s syndrome – Basic Information Pemphigus – Treatment Castleman’s disease – Basic Information Niemann-Pick disease – Trials in Disease Osteosarcoma metastatic – Treatment Hereditary neuropathic amyloidosis – Basic Information Breast angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bi 3720931 Esomeprazole Magnesium Cloxacillin Teplizumab Belinostat Odevixibat Eletriptan Dirocaftor Mitoxantrone Hyoscine L-ALANINE Amitriptyline Hypromellose Isaralgagene Civaparvovec Ketamine Mometasone Furoate Encaleret Sulfate Gen3017 Vorasidenib Belzupacap Sarotalocan More therapies…

    Learn about Your Condition

    Colitis ulcerative Coronary artery dissection Vascular malformation Angiosarcoma recurrent Endometrial cancer metastatic Tonsillitis Restless legs syndrome Uterine leiomyoma Adenocarcinoma Oesophageal carcinoma Coma Lupus nephritis Lymphangiosarcoma Hypervolaemia Epithelioid sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Eptacog Alfa (Activated)
    • Eptacog Beta (Activated)
    • Factor Viii Inhibitor Bypassing Fraction
    Bulgaria Croatia Finland Germany Norway Spain +1

  • Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Azacitidine
    Denmark Finland Norway Sweden

  • Study on Extracellular Vesicles in Hematology Patients Treated with Brexucabtagene Autoleucel and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lymphocyte adoptive therapy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Axicabtagene Ciloleucel
    • Gadobutrol
    France

  • Study on the Safety and Effectiveness of Teclistamab and Talquetamab for Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Betamethasone Sodium Phosphate
    • Bortezomib
    Germany

  • Study of pegcetacoplan safety and effectiveness in adolescents aged 12-17 with paroxysmal nocturnal hemoglobinuria

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Pegcetacoplan
    The Netherlands Spain

  • Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Valemetostat Tosilate
    Belgium France
Previous Page
1 … 18 19 20 21 22 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!